SIMCERE PHARMACEUTICAL GROUP LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of SMHGF for the last semiannual is 446.55 M USD, and it's 8.41% lower compared to the previous semiannual. The net income of H2 23 is -215.76 M USD.